Decision Making When Treating Prostate Cancer - Silke Gillessen

(Length of Discussion: 13 min)

Silke Gillessen and Alicia Morgans discuss the ERA-223 trial, the recent analysis, the direction from the FDA and EMA, and the need to be proactive with bone health in this patient population. In addition, Silke shares topics that will be discussed at the 2019 Advanced Prostate Cancer Consensus Meeting (APCCC).  

Silke Gillessen, MD, Professor Medical Oncology, University of Berne, Switzerland. Co-founder of the Advanced Prostate Cancer Consensus Conference (APCCC)

Alicia Morgans, MD, MPH


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.